When a junior high teacher assigned Chris Yiantsou to read the Hippocratic Oath in junior high school, something clicked. “I realized my personality traits matched the contents of the oath,” he said. “From that point on, studying medicine became my goal and passion in life.” So other than a brief detour when he considered a career in professional soccer (a plan his mother quickly nixed), he remained focused on that goal throughout school and eventually came to the US from Greece to study medicine.
In med school Chris was taught how to treat illness but his inclination was toward preventing it. “As I studied, I discovered that 34% of adults in the US are overweight with 35% being obese,” he said. “Obesity-related complications include diabetes, pre-diabetes, metabolic syndrome, high blood pressure, hypertension, cholesterol problems, and fatty liver disease. These are serious, life-threatening conditions. According to the National Institute of Health, obesity and overweight together are the second leading cause of preventable death in the United States, close behind tobacco use. An estimated 300,000 deaths per year are due to the obesity epidemic. Nine to 21% of the US healthcare expenditure goes toward treating these and other obesity-related conditions.”
“With perseverance, innovation, and determination, we’re treating obesity and making for a better, healthier tomorrow.”
Dr. Yiantsou decided that, rather than treating obesity-related complications, he’d direct his efforts toward preventing them. “I began my practice in 1980 with a focus on internal medicine, primarily treating GI issues including liver disease,” he said. “I became passionate about nonalcoholic fatty liver (NAFL) a disorder associated with obesity-related conditions which effects 20 and 30 % of our adult population. Approximately 20% of patients with NAFL have nonalcoholic steatohepatitis (NASH), which leads to inflammation and scarring of the liver. Of those with NASH, approximately 10% have progression to cirrhosis.”
According to Dr. Yiantsou, NASH-related cirrhosis is the third most common indication for liver transplantation in this country and is anticipated to become the leading indication. “I decided to concentrate my practice on preventing obesity, to see whether we can’t prevent liver disease as well.” And so began his association with MEDI Weightloss, a medically-supervised weight loss program that offers individualized nutrition plans and hands-on support and motivation, with a strong proven track record.
“I set forth strict guidelines regarding how we manage patients, developed by bariatric doctors and dieticians,” he said. “We look at our program as an alternative to bariatric surgery and offer highly individualized plans for each patient, see them weekly, and continually tailor their plan according to their progress and their needs.”
Treatment begins with thorough metabolic testing, to ascertain which program will work best for each patient and follows up with a maintenance program, after the weight is lost. “We’re one of the lowest cost per pound weight loss programs in this area,” Dr. Yiantsou said. When not on the job, Dr. Yiantsou enjoys spending time with his wife and kids. He’s an avid soccer fan, enjoys world travel and photography, is an active member of the Rotary Club since 1980, and one of the founding members of St. John the Baptist Church.
At MEDI Weightloss you’ll find:
- Trained Medical Staff
- Customized Weight Loss Plan
- Online Weight Loss Tracking Tools
- Nutrition & Fitness Education
- Signature Supplements & Products
- Stress-free and Uncomplicated Program
- Get off the Dieting Roller Coaster
- Rejuvenate Your Life
- Live Healthy and Lean for a Lifetime
601 E Southlake Boulevard, Suite 200
Southlake, TX 76092
Text: Meredith Knight